Evaluation of aspergillary antigenemia for monitoring neutropenic patients;Évaluation de l'antigénémie aspergillaire dans la surveillance des patients neutropéniques

Journal de Mycologie Medicale

Volumn 13, Issue 4, 2003, Pages 199-202

  Kallel, K ^a,c   Ladeb, S ^b   Belhadj, S ^a   Jerbi, A ^a   Othman, T Ben ^b   Abdelkefi, A ^b   Abdeladhim, A Ben ^b   Chaker, E ^a  

^a EPS La Rabta   (Tunisia)

^b CENTRE NATIONAL DE GREFFE DE MOELLE OSSEUSE   (Tunisia)

^c LA RABTA HOSPITAL   (Tunisia)

Author keywords

Antigenemia; Bone marrow transplant; Invasive aspergillosis; Neutropeny

Indexed keywords

ADOLESCENT; ADULT; ANTIGENICITY; ARTICLE; ASPERGILLOSIS; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FUNGUS IDENTIFICATION; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INFECTION RISK; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PATIENT MONITORING; RELIABILITY;

ASPERGILLUS; ASPERGILLUS FUMIGATUS; FUNGI; UNCLASSIFIED ORGANISMS;

EID: 0742270906     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ascioglu S, Rex JH, De Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. CID 2002;34:7-14.
2. Ben Othman T, BenLakhal R, Medini Manai Z, et al. Aspergillose pulmonaire du sujet neutropénique. A propos de 4 cas. La Tunisie Médicale 1996;74:493-500.
3. Bretagne S, Marmorat-Khuong A, Kuentz M, et al. Serum Aspergillus Galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients. J Infect 1997;35:7-15.
4. Doermann F, Accoceberry I, Weill FX, et al. Intérêt du dosage sérique de l'antigène galactomannane par méthode ELISA chez les patients présentant un risque d'aspergillose invasive dans un service d'hématologie. J Mycol Med 2002;12:131-5.
5. Kaiser L, Rochas T. Pathologies aspergillaires chez le transplanté. Rev Mal Resp 1996;13:S93-S101.
6. Kontoyiannis DP, Bodey GP. Invasive aspergillosis in 2002: an update. Eur J Microbiol Infect Dis 2002;21:161-72.
7. Machetti M, Feasi M, Mordini N, et al. Comparison of an enzym immunoassay and a latex agglutination system for the diagnosis of invasive aspergillosis in bone marrow transplant recipients. Bone Marrow Transplantation 1998;21:917-21.
8. Maertens J, Verhaegen J, Demuynck H, et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis. J Clin Microbiol 1999;37:3223-8.
9. Masahiro K, Yoshinobu K, Seishi O, Shiu-ichiro M, Tanaka Y, Honda H, et al. Frequent false positive results of Aspergillus latex agglutination test. Cancer 1999;86:274-81.
10. Rohrlich P, Sarfati J, Mariani P, et al. Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis J 1996;15:232-7.
11. Siemann M, Koch-Dörfler M. The Platelia® Aspergillus ELISA in diagnosis of invasive pulmonary aspergillosis. Mycoses 2001;44:266-72.
12. Styten D. Antigènes et anticorps spécifiques dans l'aspergillose invasive. Path Biol 1994;42:683-7.
13. Styten D, Goris A, Sarfati J, Latgé JP. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol 1995;33:497-500.
14. Sulahian A, Boutboul F, Ribaud P, Leblanc T, Rousselot P, Derouin F. Antigénémie aspergillaire: intérêt et límite de la recherche d'antigène aspergillaire en onco-hématologie. Hématologie 2000;6:106-8.
15. Verweij PE, Erjavec Z, Sluiters W, et al. Detection of antigen in sera of patients with invasive aspergillosis: intra and interlaboratory reproducibility. J Clin Microbiol 1998;36:1612-6.